Research Article
Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
Table 4
Logistic regression analysis for risk factor of hypogonadism.
| | value | SE | Wald | | OR | 95% CI |
| Age | 0.124 | 0.013 | 5.211 | 0.063 | 1.109 | 0.201–1.015 | Duration | 0.103 | 0.056 | 6.35 | 0.271 | 1.058 | 0.546–1.021 | BMI | 0.112 | 0.032 | 6.011 | 0.016 | 1.315 | 1.034–1.216 | WC | 0.183 | 0.046 | 2.811 | 0.084 | 1.136 | 0.056–1.021 | FBG | 0.078 | 0.051 | 3.938 | 0.964 | 1.076 | 0.159–1.143 | HbA1c | 0.432 | 0.165 | 6.814 | 1.523 | 0.821 | 0.113–2.140 | TG | 0.118 | 0.105 | 3.103 | 0.219 | 1.013 | 0.104–1.239 | HDL-c | 0.204 | 0.076 | 7.043 | 0.051 | 1.079 | 0.126–1.335 | FINS | 0.318 | 0.270 | 6.375 | 0.089 | 1.028 | 0.096–1.062 | HOMA-IR | 0.123 | 0.046 | 5.745 | 0.036 | 1.246 | 1.045–1.238 | LH | 0.159 | 0.157 | 8.128 | 0.047 | 1.217 | 1.021–1.153 | FSH | 0.138 | 0.144 | 7.282 | 0.052 | 1.077 | 0.018–1.067 | MS | 0.043 | 0.021 | 5.128 | 0.039 | 1.258 | 1.012–1.129 |
|
|
Note: BMI, body mass index; WC, waist circumference; FBG, fasting glucose; HbA1c, glycosylated hemoglobin; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; FINS, fasting insulin; HOMA-IR, HOMA insulin resistance; LH, luteinizing hormone; FSH, follicle-stimulating hormone; MS, metabolic syndrome.
|